Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

Featured image for “‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit’”

May 8, 2024

‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit’

  • MS Research Study and Reports
    /
In Phase 2 trials, drinkable medication with gold nanocrystals significantly reduced symptoms  By Melissa Rudy Fox News – Published April 30, 2024 5:30am…
MS Research Study and Reports
Featured image for “Breaking news: Committee favors approval of under-the-skin Ocrevus in Europe”

April 30, 2024

Breaking news: Committee favors approval of under-the-skin Ocrevus in Europe

  • MS Drug Therapies
    /
By: Andrea Lobo, PhD — Written – April 30, 2024 New formulation recommended by CHMP would be faster, easier for…
MS Drug Therapies
Featured image for “A Smoldering Process: A New Way of Thinking about Multiple Sclerosis”

April 30, 2024

A Smoldering Process: A New Way of Thinking about Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Published on: October 4, 2023 Our understanding of the biology of multiple sclerosis is changing. New research sheds light on…
MS Research Study and Reports
Featured image for “PET scans reveal ‘smoldering’ inflammation in patients with MS”

April 30, 2024

PET scans reveal ‘smoldering’ inflammation in patients with MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
April 26, 2024 A new study suggests positron emission tomography brain scans could reveal hidden inflammation in patients with multiple…
MS Research Study and Reports

April 30, 2024

What Are the Physiological Changes of Multiple Sclerosis (MS)?

  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
MS causes white blood cells to attack or injure myelin and other parts of the CNS (central nervous system). The…
Multiple Sclerosis
Featured image for “How to Spot the Signs of an MS Flare”

April 30, 2024

How to Spot the Signs of an MS Flare

  • MS Relapse-Exacerbation
    /
  • Multiple Sclerosis (MS) Symptoms
    /
When new multiple sclerosis symptoms crop up or old ones worsen, you may be having an MS relapse. By Chris…
MS Relapse-Exacerbation
Featured image for “Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis (sanofi.com)”

April 19, 2024

Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis (sanofi.com)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
April 17, 2024 Download PDF New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis…
MS Drug Therapies
Featured image for “Press Release: TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis”

April 19, 2024

Press Release: TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

  • MS Drug Therapies
    /
Apr 18, 2024 PDF Version NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), announced that…
MS Drug Therapies
Featured image for “Apr 17, 2024 – Press Release: Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis”

April 17, 2024

Apr 17, 2024 – Press Release: Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment-naïve people with relapsing multiple sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Apr 17, 2024 EAST HANOVER, N.J., April 17, 2024 — Novartis today announced data from the ALITHIOS open-label extension study showing sustained…
MS Drug Therapies

April 17, 2024

Apr 16, 2024 – Press Release: Genentech’s Subcutaneous Ocrevus One-Year Data Demonstrates Near-Complete Suppression of Clinical Relapses and Brain Lesions in Patients With Progressive and Relapsing Forms of MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Media / Press Releases Tuesday, Apr 16, 2024 Results from the Phase III study showed that subcutaneous (SC) injection was consistent with…
MS Drug Therapies

Categories

Latest Blog Posts